InsiderClue
Stocks · Technology · Laboratory Analytical Instruments

EyePoint, Inc.

EYPT Clue Score33
United States Fiscal year ends December CIK 0001314102 Results filed 19 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Karen L. Zaderej
18 Aug 2026
Director
Buy
10,600
$4.93
$52.26K
Ramiro Ribeiro
30 Jun 2026
Chief Medical Officer
Sold after exercise
2,438
$15.02
$36.61K
Ramiro Ribeiro
30 Jun 2026
Chief Medical Officer
Sold after exercise
2,437
$15.00
$36.56K
Ramiro Ribeiro
17 Apr 2026
Chief Medical Officer
Sold after exercise
2,437
$15.00
$36.56K
Jay S. Duker
16 Mar 2026
President and CEO
Buy indirect
1,500
$13.15
$19.72K
Ramiro Ribeiro
4 Mar 2026
Chief Medical Officer
Sold after exercise
2,438
$17.87
$43.57K
Ramiro Ribeiro
17 Feb 2026
Chief Medical Officer
Sold after exercise
2,437
$15.00
$36.56K
Ramiro Ribeiro
5 Jan 2026
Chief Medical Officer
Sold after exercise
42,544
$17.10
$727.32K
Nancy Lurker
4 Dec 2025
Director
Sold on a plan
9,300
$15.11
$140.48K
Cormorant Asset Management, LP
4 Dec 2025
Former 10% Owner
Sell indirect
60,000
$15.70
$942.24K
Nancy Lurker
28 Nov 2025
Director
Sold on a plan
500
$14.95
$7.48K
Nancy Lurker
26 Nov 2025
Director
Sold on a plan
200
$14.95
$2.99K
Ramiro Ribeiro
11 Nov 2025
Chief Medical Officer
Sold on a plan
2,722
$11.61
$31.60K

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 6
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 733,532
History held since 22 Oct 2007